FandosentanAlternative Names: CI 1034; PD 180988; PD 180988-0016
Latest Information Update: 12 Aug 2009
At a glance
- Originator Pfizer
- Class Benzodioxoles; Heterocyclic compounds; Small molecules
- Mechanism of Action Endothelin A receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Chronic obstructive pulmonary disease; Pulmonary hypertension